C3 rs2230199: Understanding Your Genotype and AMD Risk
The rs2230199 variant is a common genetic change in the C3 gene that alters the structure of the complement component 3 protein. Research has consistently associated this variant with an increased risk of developing age-related macular degeneration (AMD) in populations of European descent.
What each genotype means
Baseline risk profile
This genotype corresponds to the C3S (slow) allotype. Research indicates this is the baseline state for this variant, associated with a lower risk of developing age-related macular degeneration compared to those carrying the G allele.
This is the most common genotype in many populations, though frequencies vary significantly by ancestry.
Increased risk profile
This genotype represents a heterozygous state, often referred to as the C3S/F allotype. Studies suggest that carrying one copy of the G allele is associated with an increased risk of age-related macular degeneration compared to the C/C genotype.
This genotype is found in a significant portion of individuals of European descent, where the G allele frequency is approximately 20%.
Elevated risk profile
This genotype corresponds to the C3F (fast) allotype. Research indicates that individuals with this genotype have a higher statistical association with the development of age-related macular degeneration compared to those with the C/C or C/G genotypes.
This genotype is less common than the heterozygous state, occurring in a smaller percentage of the European population.
What is rs2230199?
The variant rs2230199 is a single nucleotide polymorphism (SNP) located within the C3 gene. In genetic terms, this is a coding variant, meaning it causes a change in the amino acid sequence of the protein produced by the gene. Specifically, it results in a substitution where glycine replaces arginine at a specific position in the protein chain. This change is often referred to in older literature as Arg102Gly or Arg80Gly, depending on the protein isoform numbering used. Because this change alters the physical properties of the C3 protein, it has been historically linked to different electrophoretic allotypes, known as C3S (slow) and C3F (fast). Scientists study this SNP because it serves as a marker for how the body's immune system might interact with the tissues of the eye over a lifetime.
The Role of the C3 Gene
The C3 gene provides instructions for making the complement component 3 protein, which is a central player in the complement system. This system is a vital part of the innate immune response, helping the body identify and clear pathogens or damaged cells. When the complement system is activated, C3 is cleaved into smaller fragments that trigger a cascade of immune activity, including inflammation and the recruitment of other immune cells. In the context of the eye, the complement system is thought to play a role in maintaining the health of the retina. However, if this system becomes overactive or dysregulated, it may contribute to the chronic inflammation associated with age-related macular degeneration (AMD). By studying variants like rs2230199, researchers aim to understand how subtle changes in C3 protein function might influence the risk of retinal tissue damage as people age.
Research and Evidence Strength
The association between rs2230199 and AMD is well-documented in scientific literature, particularly through large-scale genetic association studies. In populations of European descent, the G allele of this SNP is statistically linked to a higher risk of developing advanced AMD. Meta-analyses have shown that individuals carrying the G allele have higher odds of disease compared to those with the C allele. However, the evidence is considered limited in its clinical application because genetic risk is only one piece of a complex puzzle that includes environmental factors like smoking, diet, and age. Furthermore, the association is not universal; studies have found that this specific variant does not show the same risk profile in East Asian populations, where the variant is significantly less common. This highlights the importance of ancestry in interpreting genetic data, as the same variant can have vastly different implications depending on the genetic background of the population being studied.
What This Information Means for You
It is important to understand that having a specific genotype for rs2230199 does not mean you will develop AMD, nor does it guarantee you will remain free of the condition. Genetic associations are statistical observations made across large groups of people, not diagnostic tools for individuals. Many factors contribute to eye health, and genetic risk is just one component. If you are concerned about your vision or your family history of eye disease, the most effective step is to consult with an eye care professional, such as an ophthalmologist or optometrist. They can provide comprehensive eye exams and personalized advice based on your clinical history. You should never use genetic information to make medical decisions or change your health habits without professional guidance. Always discuss any concerns about your genetic results with a qualified clinician who can interpret them within the context of your overall health.
How common is this variant?
The G allele of rs2230199 has a minor allele frequency of approximately 20% in European populations, while it is rare (less than 1%) in East Asian populations.
Frequently asked questions
Does the rs2230199 variant cause macular degeneration?
No, the variant does not directly cause the disease. It is a genetic risk factor that is statistically associated with an increased likelihood of developing AMD, but many other genetic and environmental factors are involved.
Can I change my risk if I have the GG genotype?
While you cannot change your genetics, you can focus on modifiable risk factors for eye health. Consult your eye doctor about lifestyle choices, such as smoking cessation and a healthy diet, which are known to influence AMD risk.
Is this test used for clinical diagnosis?
Genetic testing for rs2230199 is generally not used for clinical diagnosis of AMD. Diagnosis is typically based on a physical examination of the retina by an eye care professional.
Why is the risk different for different ancestries?
Genetic risk factors often vary by ancestry due to differences in evolutionary history and the genetic background of populations. A variant that is common and impactful in one group may be rare or have a different effect in another.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2230199?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in C3
Complement component 3 locus variant identified in genetic association studies of age-related macular degeneration and complement activation.
A low-frequency coding variant (p.Lys155Gln) in complement component 3 that confers significant risk for developing geographic atrophy and age-related macular degeneration.
Variant in complement component 3 associated with altered susceptibility to neovascular age-related macular degeneration.
Complement component 3 variant demonstrating sex-divergent modulation of neovascular AMD susceptibility.